Compounds > phenylalanine

phenylalanine and Primary Myelofibrosis

phenylalanine has been researched along with Primary Myelofibrosis in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19901 (7.69)18.7374
1990's1 (7.69)18.2507
2000's7 (53.85)29.6817
2010's4 (30.77)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Araki, M; Endo-Umeda, K; Hashimoto, M; Hikota-Saga, R; Horiuchi, T; Izumi, T; Kato, S; Kawamura, T; Kimura, F; Kobayashi, A; Kobayashi, S; Komatsu, N; Maekawa, T; Makishima, M; Morishita, S; Nagao, S; Ogata, H; Okada, Y; Osawa, Y; Saito, K; Sato, K; Sone, T; Suzu, S; Tachi, N; Takada, K; Takano, K; Teramoto, M; Uno, S; Usuki, K1
Chen, SS; Gale, RP; Huang, XJ; Jiang, B; Jiang, H; Jiang, Q; Li, JL; Li, LD; Li, N; Liu, KY; Ruan, GR; Shi, HX; Yao, QM; Zhao, XS1
Al-Ali, HK; Gopalakrishna, P; Hubert, K; Koehler, A; Lange, T; Monecke, A; Niederwieser, D; Siebolts, U; Wickenhauser, C1
Ammatuna, E; Antonioli, E; Barbui, T; Barosi, G; Bosi, A; Delaini, F; Guglielmelli, P; Liso, V; Lo Coco, F; Longo, G; Pancrazzi, A; Pieri, L; Ponziani, V; Rambaldi, A; Specchia, G; Vannucchi, AM1
Iványi, JL; Marton, E; Plander, M1
DeWald, GW; Lasho, T; McClure, R; Mesa, RA; Powell, H; Tefferi, A1
Hasselbalch, HC; Kerndrup, GB; Larsen, TS; Pallisgaard, N1
Andrikovics, H; Csukly, Z; Halm, G; Király, V; Lovas, N; Lueff, S; Masszi, T; Mátrai, Z; Meggyesi, N; Mikala, G; Nahajevszky, S; Sipos, A; Szilvási, A; Tamáska, J; Tordai, A1
Bödör, C; Csernus, B; Csomor, J; Matolcsy, A; Rajnai, H; Reiniger, L; Szepesi, A; Timár, B1
Beelen, DW; Ditschkowski, M; Elmaagacli, AH; Koldehoff, M; Steckel, NK1
Dirnhofer, S; Hao-Shen, H; Looser, R; Schwaller, J; Skoda, RC; Sobas, MA; Tiedt, R1
Pangalis, GA; Tsavaris, NB1
Canellos, GP; DeVita, VT; Mason, JE1

Other Studies

13 other study(ies) available for phenylalanine and Primary Myelofibrosis

ArticleYear
Increased SLAMF7
    Blood, 2019, 09-05, Volume: 134, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Antibodies, Monoclonal, Humanized; Blood Cell Count; Cell Proliferation; Cross-Sectional Studies; Female; Humans; Janus Kinase 2; Male; Middle Aged; Molecular Targeted Therapy; Monocytes; Mutation, Missense; Phenylalanine; Primary Myelofibrosis; Signaling Lymphocytic Activation Molecule Family; Valine

2019
Frequency and allele burden of CALR mutations in Chinese with essential thrombocythemia and primary myelofibrosis without JAK2(V617F) or MPL mutations.
    Leukemia research, 2015, Volume: 39, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amino Acid Sequence; Amino Acid Substitution; Asian People; Base Sequence; Calreticulin; Female; Gene Frequency; Genotype; Humans; Janus Kinase 2; Male; Middle Aged; Molecular Sequence Data; Mutation; Phenylalanine; Primary Myelofibrosis; Receptors, Thrombopoietin; Thrombocythemia, Essential; Valine; Young Adult

2015
JAK2V617F molecular remission in a primary myelofibrosis patient treated with ruxolitinib.
    Annals of hematology, 2015, Volume: 94, Issue:11

    Topics: Amino Acid Substitution; Humans; Janus Kinase 2; Male; Middle Aged; Nitriles; Phenylalanine; Primary Myelofibrosis; Pyrazoles; Pyrimidines; Remission Induction; Valine

2015
Identification of patients with poorer survival in primary myelofibrosis based on the burden of JAK2V617F mutated allele.
    Blood, 2009, Aug-20, Volume: 114, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Alleles; Amino Acid Substitution; DNA Mutational Analysis; Female; Genetic Predisposition to Disease; Humans; Janus Kinase 2; Male; Middle Aged; Mutation, Missense; Phenylalanine; Primary Myelofibrosis; Prognosis; Survival Analysis; Valine; Young Adult

2009
[Significance of the JAK2V617F mutation in patients with chronic myeloproliferative neoplasia].
    Orvosi hetilap, 2011, Nov-06, Volume: 152, Issue:45

    Topics: Adult; Aged; Bone Marrow Neoplasms; Chronic Disease; Female; Humans; Janus Kinase 2; Male; Middle Aged; Mutation; Myeloproliferative Disorders; Phenylalanine; Polycythemia Vera; Polymerase Chain Reaction; Predictive Value of Tests; Primary Myelofibrosis; Retrospective Studies; Signal Transduction; Thrombocythemia, Essential; Thrombosis; Valine

2011
A longitudinal study of the JAK2(V617F) mutation in myelofibrosis with myeloid metaplasia: analysis at two time points.
    Haematologica, 2006, Volume: 91, Issue:3

    Topics: Humans; Janus Kinase 2; Longitudinal Studies; Mutation; Phenylalanine; Primary Myelofibrosis; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Up-Regulation; Valine

2006
A der(18)t(9;18)(p13;p11) and a der(9;18)(p10;q10) in polycythemia vera associated with a hyperproliferative phenotype in transformation to postpolycythemic myelofibrosis.
    Cancer genetics and cytogenetics, 2007, Jan-15, Volume: 172, Issue:2

    Topics: Aged; Cell Proliferation; Cell Transformation, Neoplastic; Chromosomes, Human, Pair 18; Chromosomes, Human, Pair 9; Female; Humans; Janus Kinase 2; Male; Middle Aged; Phenotype; Phenylalanine; Polycythemia Vera; Primary Myelofibrosis; Translocation, Genetic; Valine

2007
[Role of the activating mutation Val617Phe of Janus kinase 2 gene in myeloproliferative diseases and significance of its detection].
    Orvosi hetilap, 2007, Feb-04, Volume: 148, Issue:5

    Topics: Adult; Aged; Biopsy; Bone Marrow; Female; Gene Expression Regulation; Gene Frequency; Humans; Janus Kinase 2; Male; Middle Aged; Myeloproliferative Disorders; Phenotype; Phenylalanine; Point Mutation; Polycythemia Vera; Polymerase Chain Reaction; Primary Myelofibrosis; Thrombocytosis; Valine

2007
[Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].
    Orvosi hetilap, 2006, Nov-12, Volume: 147, Issue:45

    Topics: Alleles; Amino Acid Sequence; Base Sequence; Biomarkers, Tumor; Genetic Markers; Humans; Janus Kinase 2; Leukemia; Molecular Sequence Data; Myeloproliferative Disorders; Phenylalanine; Point Mutation; Polycythemia Vera; Polymerase Chain Reaction; Primary Myelofibrosis; Signal Transduction; Thrombocytopenia; Valine

2006
Use of the activating gene mutation of the tyrosine kinase (VAL617Phe) JAK2 as a minimal residual disease marker in patients with myelofibrosis and myeloid metaplasia after allogeneic stem cell transplantation.
    Transplantation, 2007, Jun-15, Volume: 83, Issue:11

    Topics: Adult; Biomarkers; Computer Systems; Feasibility Studies; Female; Follow-Up Studies; Gene Expression Regulation; Humans; Janus Kinase 2; Male; Middle Aged; Mutation; Phenylalanine; Polymerase Chain Reaction; Primary Myelofibrosis; Recurrence; Retrospective Studies; Stem Cell Transplantation; Transplantation Chimera; Transplantation, Homologous; Valine

2007
Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice.
    Blood, 2008, Apr-15, Volume: 111, Issue:8

    Topics: Animals; Colony-Forming Units Assay; Granulocytes; Hematopoiesis, Extramedullary; Humans; Hyperplasia; Integrases; Janus Kinase 2; Megakaryocytes; Mice; Mice, Transgenic; Mutant Proteins; Myeloproliferative Disorders; Phenotype; Phenylalanine; Polycythemia Vera; Primary Myelofibrosis; Recombination, Genetic; Thrombocythemia, Essential; Transgenes; Valine

2008
Neutrophil 5-nucleotidase reaction in chronic myelogenous leukemia, myelofibrosis with myeloid metaplasia, and polycythemia vera.
    Annals of hematology, 1998, Volume: 76, Issue:1

    Topics: 5'-Nucleotidase; Adenosine Diphosphate; Adjuvants, Immunologic; Alkaline Phosphatase; Enzyme Inhibitors; Homoarginine; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Levamisole; Neutrophils; Phenylalanine; Polycythemia Vera; Primary Myelofibrosis

1998
Thrombocytosis in chronic granulocytic leukemia: incidence and clinical significance.
    Blood, 1974, Volume: 44, Issue:4

    Topics: Anemia; Azauridine; Blood Cell Count; Blood Platelets; Bone Marrow Examination; Busulfan; Cell Transformation, Neoplastic; Humans; Hydroxyurea; Karyotyping; Leukemia, Myeloid; Mitolactol; Nitrogen Mustard Compounds; Phenylalanine; Primary Myelofibrosis; Prognosis; Splenomegaly; Thrombocytosis

1974